News
Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read ...
Cigna, a $90 billion healthcare behemoth, may fly under the radar, but don't let its quiet facade fool you. The company boasts a robust $180 billion in annual revenue and a striking 20%+ return on ...
Caremark will provide outpatient prescription drug benefits to nearly 587,000 members enrolled in Basic or Medicare HMO and PPO plans, which is roughly 40% of CalPERS’ 1.5 million beneficiaries. CVS ...
Key Takeaways Health insurance firms were some of Thursday's worst-performing stocks in both the S&P 500 and Dow Jones Industrial Average.Elevance Health shares plunged after the insurer lowered its ...
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $300.0 and $340.0 for Cigna Group, spanning the last three months ...
The Cigna Group is set to report its Q2 2025 earnings on July 31, with analysts expecting a 6.3% profit jump year-over-year.
CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.
Cigna Group is expected to release its fiscal second-quarter earnings later this month, and analysts project a single-digit ...
Cigna trades at a significant discount to the S&P 500, offering a higher yield and faster dividend growth, making it ...
UnitedHealth Group Incorporated UNH and The Cigna Group CI are two leading players in U.S. managed care insurance, offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results